General Physician, Universidad Del Sinu, Monteria, Colombia
Review Article
Use of Anti-Mononuclear Antibodies as Therapy for Covid-19
Author(s): Jhon Fredy Bello Cordero*, Urbano David Benitez Russo, Fernan Andres Torres Hernandez, Jesus Miguel Moreno Martinez, Mayerly del Carmen Mercado Oliva, Daniel Nicolas Pinilla Lopez, Miguel Angel Iglesias Herrera and Jhoyner Alberto Jimenez Filigrana
The disease caused by a B-coronavirus, an RNA virus, had its beginnings in 2019 in Wuhan - China where a series of cases of pneumonia caused by this agent were identified, after sequencing the nucleic acid of the epithelial cells of the lower respiratory tract of 4 patients with confirmed pneumonia of unknown cause by realtime reverse transcription PCR at Beijing Hospital, a new beta coronavirus 2019-nCoV, which was later named SARS-CoV-2, was found. Currently there are only maintenance therapies and symptom management, since there are no exact therapies for the management of severe SarsCoV2 infection, antiviral drugs and other drugs used to manage the infection such as acyclovir, panciclovir, chloroquine are used , ganciclovir, remdesivir, nitazoxadine, corticosteroids among other medications currently used for symptom management- The use of neutralizing antibody therapy may alter t.. View More»
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 